Cargando…
1066. Immune Escape Mutant Detection Using Commercially Available Methods for Hepatitis B Surface Antigen Serological Testing
BACKGROUND: Although overall infection rates of Hepatitis B virus (HBV) in the United States (US) remain stable, as many as 2.2 million persons are still chronically infected with Hepatitis B Virus (HBV)1. Persons who inject drugs (PWID) are at a higher risk of HBV infection and since 2009 three sta...
Autores principales: | Gish, Robert, Streva, Vincent |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776757/ http://dx.doi.org/10.1093/ofid/ofaa439.1252 |
Ejemplares similares
-
1066. In Vitro and in Vivo Antimicrobial Activity of Cefiderocol and Comparators against Achromobacter spp
por: Nakai, Ryuichiro, et al.
Publicado: (2021) -
1066 Delay in the Norwegian Immunisation Programme
por: Riise, Oystein
Publicado: (2014) -
1066. Antimicrobial Stewardship Program: Audit and Feedback for Continued Improvement
por: Wang, Joseph, et al.
Publicado: (2019) -
A simple and inexpensive point-of-care test for hepatitis B surface antigen detection: serological and molecular evaluation
por: Gish, R G, et al.
Publicado: (2014) -
Evaluation of Commercially Available Serologic Diagnostic Tests for Chikungunya Virus
por: Prat, Christine M., et al.
Publicado: (2014)